Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Prognostic factors for newly diagnosed Acute Myeloid Leukemia with FLT3-TKD - a multicenter retrospective study

Blood (2025) 146 (Supplement 1): 5182.

https://doi.org/10.1182/blood-2025-5182

Published: 2025

Journal Articles

Etoposide + cytarabine + pegfilgrastim vs cyclophosphamide + granulocyte colony-stimulating factor for stem-cell mobilization in patients with multiple myeloma: A phase III trial

Peipei Ye, Renzhi Pei, Lihong Shou, Jie Jin, Hongyan Tong, Huifang Jiang, Linlong Xu, Jian Shen, Sai Chen, Gongqiang Wu, Dong Chen, Shuangyue Li, Jingcheng Zhang, Huang Li, Fujiang Song, Weiying Feng, Chao Hu, Ying Lu

Blood (2025) 146 (Supplement 1): 5960.

https://doi.org/10.1182/blood-2025-5960

Published: 2025

Journal Articles

Etoposide-cytarabine-pegfilgrastim (EAP) and disease-specific chemotherapy regimens for hematopoietic stem cell mobilization in lymphoma: A randomized phase III trial

Peipei Ye, Renzhi Pei, Jie Jin, Hongyan Tong, Lihong Shou, Huifang Jiang, Jingcheng Zhang, Sai Chen, Linlong Xu, Yanping Shao, Dong Chen, Shuangyue Li, Huang Li, Jing le, Yangxi Jin, Chao Hu, Ying Lu

Blood (2025) 146 (Supplement 1): 4182.

https://doi.org/10.1182/blood-2025-4182

Published: 2025

Journal Articles

A prospective, multicenter study on stem cell mobilization using EAP regimen as first-line mobilization in patients with multiple myeloma and lymphoma

Blood (2025) 146 (Supplement 1): 4179.

https://doi.org/10.1182/blood-2025-4179

Published: 2025

Journal Articles

Screening and Validation of Natural Product with Anti ETP-ALL Activity Using a Novel ETP-ALL Cell Line

Fenglin Li, Haihui Zhuang, Renzhi Pei, Jie Jin, Ying Lu

Blood (2024) 144 (Supplement 1): 5847.

https://doi.org/10.1182/blood-2024-204632

Published: 2024

Journal Articles

Analysis of Risk Factors and Development of a Nomogram Prediction Model for Stem Cell Mobilization Failure in Lymphoma Patients

Qingqing Lin, Peipei Ye, Renzhi Pei, Jie Jin, Ying Lu

Blood (2024) 144 (Supplement 1): 5597.

https://doi.org/10.1182/blood-2024-204577

Published: 2024

Journal Articles

The Effect and Mechanism of Venetoclax in Combination with SAR405 in Acute Myeloid Leukemia

Youhong Li, Xia Jiang, Lei Jiang, Ying Lu, Jie Jin, Renzhi Pei

Blood (2024) 144 (Supplement 1): 5816.

https://doi.org/10.1182/blood-2024-204758

Published: 2024

Journal Articles

Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: A Prospective, Multicenter, Phase 2 Trial

Blood (2024) 144 (Supplement 1): 836.

https://doi.org/10.1182/blood-2024-208355

Published: 2024

Journal Articles

ARPC2 Targeting Inhibition Progress the Proliferation Suppression of Acute Myeloid Leukemia through PI3K-AKT Pathway

Chunxiao Chen, Fenglin Li, Ying Lu, Renzhi Pei, Jie Jin, Haihui Zhuang, Shuangyue Li

Blood (2024) 144 (Supplement 1): 6101.

https://doi.org/10.1182/blood-2024-204566

Published: 2024

Journal Articles

Wogonin Induces Apoptosis of Acute Myeloid Leukemia Cells through PI3K/Akt Pathway and Synergies with Venetoclax

Xia Jiang, Youhong Li, Lei Jiang, Renzhi Pei, Jie Jin, Ying Lu

Blood (2024) 144 (Supplement 1): 5803.

https://doi.org/10.1182/blood-2024-204697

Published: 2024

Journal Articles

G Protein-Coupled Receptor 183 Mediates Homoharringtonine Resistance Via NF-Κb Pathway in Acute Myeloid Leukemia

Haihui Zhuang, Fenglin Li, Rongzhen Xu, Renzhi Pei, Jie Jin, Ying Lu

Blood (2024) 144 (Supplement 1): 5793.

https://doi.org/10.1182/blood-2024-204563

Published: 2024

Journal Articles

Cytarabine Plus Etoposideis+Peg-Rhg-CSF Is More Effective Than Cyclophosphamide + G-CSF As a Stem Cell Mobilization Regimen in Poorly Mobilized MM and Lymphoma

Yixuan Cheng, Dong Chen, Renzhi Pei, Xiaohong Du, Chen Li, Xianxu Zhuang, Fenglin Li, Peipei Ye, Ying Lu

Blood (2023) 142 (Supplement 1): 7103.

https://doi.org/10.1182/blood-2023-185595

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Prognostic factors for newly diagnosed Acute Myeloid Leukemia with FLT3-TKD - a multicenter retrospective study

Etoposide + cytarabine + pegfilgrastim vs cyclophosphamide + granulocyte colony-stimulating factor for stem-cell mobilization in patients with multiple myeloma: A phase III trial

Etoposide-cytarabine-pegfilgrastim (EAP) and disease-specific chemotherapy regimens for hematopoietic stem cell mobilization in lymphoma: A randomized phase III trial

A prospective, multicenter study on stem cell mobilization using EAP regimen as first-line mobilization in patients with multiple myeloma and lymphoma

Screening and Validation of Natural Product with Anti ETP-ALL Activity Using a Novel ETP-ALL Cell Line

Analysis of Risk Factors and Development of a Nomogram Prediction Model for Stem Cell Mobilization Failure in Lymphoma Patients

The Effect and Mechanism of Venetoclax in Combination with SAR405 in Acute Myeloid Leukemia

Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: A Prospective, Multicenter, Phase 2 Trial

ARPC2 Targeting Inhibition Progress the Proliferation Suppression of Acute Myeloid Leukemia through PI3K-AKT Pathway

Wogonin Induces Apoptosis of Acute Myeloid Leukemia Cells through PI3K/Akt Pathway and Synergies with Venetoclax

G Protein-Coupled Receptor 183 Mediates Homoharringtonine Resistance Via NF-Κb Pathway in Acute Myeloid Leukemia

Cytarabine Plus Etoposideis+Peg-Rhg-CSF Is More Effective Than Cyclophosphamide + G-CSF As a Stem Cell Mobilization Regimen in Poorly Mobilized MM and Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only